Abstract. Oxidative damage is a key factor for the pathogenesis of age-related macular degeneration (AMD), therefore, anti-oxidative stress is a valuable method for the prevention or treatment of AMD. The aim of the present study was to reveal the protective mechanism of lutein on retinal pigment epithelium (RPE) cells subjected to oxidative stress. Acute retinal pigment epithelial 19 (ARPE-19) cells were exposed to oxidative stress induced by H 2 O 2 following lutein pretreatment. The activities of caspases, level of intracellular reactive oxygen species (ROS) and cell cycle were analyzed using flow cytometry. The expression levels of cell cycle regulatory proteins and inflammation-associated genes were detected using western blot and reverse transcription-polymerase chain reaction analyses, respectively. The data showed that oxidative stress reduced cell viability, and increased total apoptosis and ROS generation, however, lutein prevented cells from oxidative stress-induced damage. In addition, oxidative damage triggered G 2 /M phase arrest of the ARPE-19 cells, which was reversed by lutein in a concentration-dependent manner, through the activation of cyclin-dependent kinase 1 and cell division cycle 25C, and degradation of cyclin B1. These results demonstrated that lutein may be an effective antioxidant, which can be applied in the prevention of AMD, or other age-related diseases associated with oxidative damage.
Introduction
Age-related macular degeneration (AMD) is the leading cause of visual loss among individuals >65 years of age in developed countries (1) . The most common type of AMD, also termed the 'dry-type', is initiated by the death of retinal pigment epithelium (RPE) cells and eventually results in the degeneration of photoreceptors, which leads to visual loss (2, 3) . AMD is a multifactorial disease; aging, genetic background, cigarette smoking, oxidative damage and chronic inflammation are all factors, which contribute to its onset and progression (4) (5) (6) .
It is well established that oxidative stress is important in the pathogenesis of AMD (7, 8) . The retina requires a higher oxygen concentration, compared with other organs, in order to maintain the high metabolic rate of photoreceptors. The higher the level of oxygen consumed, the more reactive oxygen species (ROS) is produced. In addition, the daily phagocytosis of shed photoreceptor outer segments leads to the generation of free radicals and toxic oxidized materials in RPE cells. Therefore, RPE cells are susceptible to long-term oxidative stress, and oxidative stress induces the dysfunction of RPE cells, contributing to the development of AMD (2, 9) . There remains no effective treatment for the dominant type of AMD, and current interventions are commonly focused on prevention rather than treatment. Antioxidant supplements have been used to reduce the risk of AMD, and dietary lutein is considered to act as a protector against visual impairment from AMD (10) .
Lutein is a type of carotenoid, which forms human macular pigments with zeaxanthin in the retina, inhibiting noxious blue light into retina and contributing to strengthening of the antioxidant defense of RPE cells (11, 12) . The human body cannot synthesize lutein. The sources of lutein are primarily dietary in origin, for example, green leafy vegetables, including spinach and cabbage; fruits, including grapes and kiwis; egg yolks, and corn (13) . It is reported that the risks of the onset and progression of AMD are negatively correlated with lutein concentration in the macula (5, 14) .
Lutein has already been used in the healthcare setting (15), however, the exact molecular mechanism underlying the protective effect of lutein against stress remains to be fully Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. Total RNA was extracted with TRIzol reagent (Takara Bio, Inc., Shiga, Japan). A 1 µg sample of RNA was reverse transcribed using a PrimeScript™ RT reagent kit (Takara Bio, Inc.), and the mixtures were incubated at 37˚C for 15 min and 85˚C for 5 sec. Subsequently, 1 µl (10 ng/µl) DNA was added to 5 µl SYBR Green I, 0.5 µl (10 µM) forward primer, 0.5 µl (10 µM) reverse primer and 3 µl ddH 2 O, using the Universal qPCR kit (Kapa Biosystems, Wilmington, MA, USA). The qPCR was performed on a LightCycler ® 96 sequence detection system (Roche Diagnostics, Basel, Switzerland) according to the manufacturer's protocol. The LightCycler ® 96 application software version 1.1 was used for data collection and analysis. Relative quantitative analysis of interleukin (IL)-6, IL-8 and tumor necrosis factor-α (TNF-α) mRNAs were performed using the 2 -ΔΔCq method with normalization to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA (16) . The system settings were as follows: Preincubation at 95˚C for 60 sec and amplification at 72˚C for 10 sec for 45 cycles, and melting at 97˚C for 1 sec. The primer sets were designed as shown in Table I .
Western blot analysis. The cell proteins were extracted on ice using lysis buffer solution (20 mM Tris HCl, 150 mM NaCl, 10% glycerol, 1% NP-40, 2.1 g NaF, 1 mM PMSF, 1 mM Na 3 VO 4 , 10 µg/ml aptotin, 2 µg/ml leupeptin and 420 ml H 2 O) containing phosphatase inhibitor (PhosSTOP; Merck Millipore). Protein concentrations were measured using a bicinchoninic acid assay kit (catalog no. C503021, Sangon Biotech Co., Ltd., Shanghai, China). A total of 20 µg protein from each sample was loaded onto 10% gels and subjected to SDS-PAGE, prior to transfer onto a nitrocellulose membrane for 75 min. The membrane was sealed with 5% defatted milk for 1 h, incubated with primary antibodies at 4˚C overnight, and washed with 1X TBST for 10 min three times. The membrane was then incubated with secondary antibodies for 1 h at room temperature and washed with 1X TBST for 10 min three times. The ECL reagent Immobilon™ Western (EMD Millipore, Billerica, MA, USA) was added to the membranes for 1-3 min, and the immunofluorescence reaction was observed using a western blot luminescence imaging system (Tanon-5200; Tanon, Shanghai, China) and image analysis software (Gel Image System Ver. 4.2.5; Tonon). The antibodies used included tubulin α (cat. no. AF7010; Affinity Biotech, Kansas, MO, USA, GAPDH (cat. no. 60004-1-Ig; Proteintech Group, Inc., Wuhan, China), cyclin-dependent kinase 1 (CDK1; cat. no. BM1028; Boster Biotech, Wuhan, China), cyclin B1 (cat. no. BM0766; Boster Biotech) and cell division cycle 25C (CDC25C; cat. no. BM2728; Boster Biotech). The primary antibodies were diluted 1:500 and an anti-mouse IgG horseradish peroxidase-conjugated secondary antibody (catalog. no. 7076S) or an anti-rabbit IgG Alexa Fluor ® 555-conjugated secondary antibody (catalog no. 4413) from Cell Signaling Technology, Inc., Danvers, MA, USA, were diluted 1:2,000.
Statistical analysis. Each experiment was performed in triplicate. All analyses were performed using SPSS version 22.0 (IBM SPSS, Armonk, NY, USA). The data are expressed as the mean ± standard deviation and were statistically compared using Student's t-test. P<0.05 was considered to indicate a statistically significant difference.
Results

Cell viability of RPE cells following treatment with lutein and H 2 O 2 .
The cytotoxicity of lutein was assessed using an MTT assay for 3 days. Different concentrations of lutein were added to the cultural media of RPE cells. Compared with the control group of RPE cells cultured without treatment, the cell viability and proliferation of the RPE cells remained unchanged with concentrations of lutein up to 15 µM (Fig. 1A) .
The RPE cells were treated with different concentrations of H 2 O 2 (0-2,000 µM) for 24 h. Cell viability was also evaluated using an MTT assay. The results revealed that the cell viability reduced to ~50% of that in the control when the concentration of H 2 O 2 reached 800 µM (Fig. 1B) . Based on this result, 800 µM was selected as the concentration for inducing apoptosis and the production of ROS. (Fig. 2A) .
Lutein increases cell viability, and decreases apoptosis and ROS in RPE cells
The expression levels of total caspases in the RPE cells increased to 66.3% when the cells were exposed to H 2 O 2 , compared with 11.1% in the control group. Lutein inhibited the increased expression of total caspases in a concentration-dependent manner. Following retreatment with lutein at concentrations of 5 and 10 µM, the expression of total caspases in RPE cells reduced to 49.3 and 26.9%, respectively. (Fig. 2B) .
In the RPE cells treated with H 2 O 2 , the ROS levels increased to 65.21%, compared with 10.76% in the control group. Lutein reversed the elevation in ROS levels. The ROS levels reduced to 52.8 and 42.4% when the RPE cells were pretreated with 5 and 10 µM lutein, respectively (Fig. 2C) .
Lutein increases the expression of IL-6, IL-8 and TNF-α inflammatory cytokines in RPE cells treated with H 2 O 2 .
In the present study, H 2 O 2 markedly increased the expression levels of the IL-6, IL-8 and TNF-α inflammatory cytokines in the RPE cells (Fig. 3) . When the RPE cells were pretreated with lutein at a concentration of 10 µM, the transcription levels of these inflammatory cytokines were also elevated, although pretreatment with lutein at a concentration of 5 µM did not alter the expression of these inflammatory cytokines.
Lutein reduces RPE G 2 /M phase arrest induced by H 2 O 2 .
When the concentration of H 2 O 2 reached 400 µM, cell cycle arrest of the RPE cells was observed in the G 2 /M phase. (Fig. 4A) . It was found that, in the RPE cells treated with 600 µM H 2 O 2 , the proportion of cells in the G 2 /M phase was 47.3%, compared with 35.9% in the control group. Lutein reversed the increased proportion of cells in the G 2 /M phase in a concentration-dependent manner. When the cells were pretreated with 5 and 10 µM lutein, the proportions of RPE cells in the G 2 /M phase were reduced to 40.8 and 33.4%, respectively (Figs. 4B and 5A).
Lutein attenuates RPE cell cycle arrest in the G 2 /M phase by activating CDK1 and CDC25C, and decreasing cyclin B1.
When the RPE cells were treated with H 2 O 2 , the expression levels of CDK1 and CDC25C were inhibited, and the protein expression of of cyclin B1 was increased in the cells. However, the inactivation of CDK1 and CDC25C, and increase of cyclin B1 were attenuated when lutein was added to the cells (Fig. 5B and C) .
Discussion
In the present study, it was demonstrated that the oxidative stress triggered by H 2 O 2 decreased cell viability, increased intracellular ROS and increased apoptosis in RPE cells. It was noted that marked G 2 /M phase arrest occurred in the RPE cells when subjected to H 2 O 2 and for the first time, to the best of our knowledge, it was found that lutein attenuated this G 2 /M arrest in a concentration-dependent manner.
Lutein is present at a high concentration in the macula of the eye (17) . It contains several double bonds, which react with ROS to scavenge free radicals (1) . Lutein functions as a cytoprotective antioxidant in a direct anti-apoptotic or indirect anti-oxidation manner (12, 18) . In addition, the reversal of G 2 /M phase arrest observed in oxidative stressed cells induced by lutein contribute to its role in cell protection.
When DNA is damaged, the G 2 checkpoint inhibits cells entering mitosis. The cell cycle arrest provides an opportunity for repair and inhibits proliferation of the damaged cells (19) . In Hl299 cells, DNA damage and G 2 /M phase arrest were found to be induced by oxidative damage, whereas an antioxidant in red seaweed Gracilaria tenuistipitata protected the cells from DNA damage and G 2 /M arrest (20) . The results of the initiation of mitosis. CDC25 is also a key regulator, which activates CDK1 and drives cell cycle progression (21) . In the present study, when the RPE cells were subjected to oxidative stress, a significant increase in cyclin B1 and deceases in CDK1 and CDC25C were observed, which suggested that cell cycle progression was inhibited prior to entering the mitosis phase. This suggestion was confirmed by the analysis of cell cycle using flow cytometry, as RPE cells in the G 2 /M phase increased when exposed to H 2 O 2 . However, lutein protected the RPE cells from G 2 /M phase arrest by degrading the cyclin B1 protein, and increasing the activities of CDK1 and CDC25C in a concentration-dependent manner. As the results of the flow cytometry indicated, fewer RPE cells were arrested in the G 2 /M phase when treated with lutein.
Increasing evidence has indicated the role of inflammation in the pathogenesis of AMD. Inflammatory proteins make up the composition of drusen in AMD, and RPE cells are a rich resource of inflammatory cytokines (11, 22, 23) . Lutein prevents the proteasome from inactivation by photo-oxidative damage and alters the expression of the inflammatory-associated genes, monocyte chemoattractant protein-1, IL-8 and complement factor H in RPE cells (11) . Lutein also exerts an anti-inflammatory effect in the ischemic/hypoxic retina by reducing the expression of IL-1β and cyclooxygenase 2 in rMC-1 cells (24) . The present study demonstrated that H 2 O 2 treatment upregulated the expression of the inflammation-associated genes, IL-6, IL-8 and TNF-α. At concentrations >10 µM, lutein increased the expression levels of IL-6, IL-8 and TNF-α. These results improve current understanding of the effect of lutein on inflammation and indicated the potential cytotoxic effect of lutein; therefore, the use of large concentrations of lutein requires caution (25) .
In conclusion, the present study demonstrated that lutein protected RPE cells from oxidative damage, and reversed G 2 /M phase arrest through activating CDK1 and CDC25C, and degrading the protein expression of cyclin B1. As AMD is a disease prevailing worldwide and a socioeconomic burden requiring resolution, dietary lutein supplementation may offer a suitable measure for preventing AMD.
